MFDS — authorised 26 November 2018
- Marketing authorisation holder: LOXO ONCOLOGY INC
- Status: likely_approved
🇰🇷 Vitrakvi in South Korea
MFDS authorised Vitrakvi on 26 November 2018
Marketing authorisation
Vitrakvi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Vitrakvi approved in South Korea?
Yes. MFDS authorised it on 26 November 2018.
Who is the marketing authorisation holder for Vitrakvi in South Korea?
LOXO ONCOLOGY INC holds the South Korean marketing authorisation.